Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Kang, Tae Wook ^a   Choi, Soon Won ^a   Yang, Se Ran ^b   Shin, Tae Hoon ^a   Kim, Hyung Sik ^a   Yu, Kyung Rok ^a   Hong, In Sun ^c   Ro, Seonggu ^d   Cho, Joong Myung ^d   Kang, Kyung Sun ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

^c Gachon University   (South Korea)

^d Crystal Genomics   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT; CG500354; CREB1 PROTEIN, HUMAN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN P53; THIAZOLE DERIVATIVE; TP53 PROTEIN, HUMAN;

ANIMAL; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; FEMALE; GLIOBLASTOMA; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANILINE COMPOUNDS; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GLIOBLASTOMA; HUMANS; MICE, INBRED NOD; MICE, SCID; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; THIAZOLES; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903974202     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05546     Document Type: Article

References (51)

1. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006). (Pubitemid 44949604)
2. Liu, G. et al. Analysis of gene expression and chemoresistance of CD1331cancer stem cells in glioblastoma. Mol Cancer 5, 67 (2006).
3. Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459-466 (2009).
4. Beck, B. & Blanpain, C. Unravelling cancer stem cell potential. Nat Rev Cancer 13, 727-738 (2013).
5. Peh, G. S., Lang, R. J., Pera, M. F. & Hawes, S. M. CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation. Stem Cells Dev 18, 269-282 (2009).
6. Carter, D. A., Dick, A. D. Mayer, E. J. CD1331adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF). BMC Ophthalmol 9, 1 (2009).
7. Uchida, N. et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97, 14720-14725 (2000). (Pubitemid 32016642)
8. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004). (Pubitemid 39551674)
9. Singh, S. & Dirks, P. B. Brain tumor stem cells: identification and concepts. Neurosurg Clin N Am 18, 31-38, viii (2007). (Pubitemid 46161197)
10. Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15, 504-514 (2008). (Pubitemid 351267301)
11. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65, 10946-10951 (2005). (Pubitemid 41713363)
12. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001). (Pubitemid 33041634)
13. Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64, 7011-7021 (2004). (Pubitemid 39331011)
14. Yuan, X. et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392-9400 (2004). (Pubitemid 40069671)
15. Beier, D. et al. CD133(1) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67, 4010-4015 (2007). (Pubitemid 46815044)
16. Lathia, J. D. et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6, 421-432 (2010).
17. Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761-765 (2006). (Pubitemid 44949605)
18. de The, H. & Chen, Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer 10, 775-783 (2010).
19. Nasr, R. et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med 14, 1333-1342 (2008).
20. Guillemin, M. C. et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med 196, 1373-1380 (2002).
21. Goldhoff, P. et al. Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clin Cancer Res 14, 7717-7725 (2008).
22. Yang, L., Jackson, E., Woerner, B. M., Perry, A., Piwnica-Worms, D. & Rubin, J. B. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res 67, 651-658 (2007). (Pubitemid 46192204)
23. Moreno, M. J., Ball, M., Andrade, M. F., McDermid, A. & Stanimirovic, D. B. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 53, 845-857 (2006).
24. Mayr, B. M., Canettieri, G. & Montminy, M. R. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc Natl Acad SciUS A98, 10936-10941 (2001). (Pubitemid 32878722)
25. Mayr, B. & Montminy, M. Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2, 599-609 (2001). (Pubitemid 33674011)
26. Siddappa, R. et al. CAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105, 7281-7286 (2008). (Pubitemid 351754469)
27. Sato, K. et al. Regulation of osteoclast differentiation and function by the CaMKCREB pathway. Nat Med 12, 1410-1416 (2006). (Pubitemid 44924500)
28. Zhao, Q. et al. Rapid induction of cAMP/PKA pathway during retinoic acidinduced acute promyelocytic leukemia cell differentiation. Leukemia 18, 285-292 (2004). (Pubitemid 38240044)
29. Lucchi, S., Calebiro, D., de Filippis, T., Grassi, E. S., Borghi, M. O. & Persani, L. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms. PLoS One 6, e20785 (2011).
30. Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R. & Vallar, L. GTPase inhibitingmutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692-696 (1989). (Pubitemid 19214389)
31. Kirschner, L. S. et al. Mutations of the gene encoding the protein kinase A type Ialpha regulatory subunit in patients with the Carney complex. Nat Genet 26, 89-92 (2000).
32. Lania, A., Mantovani, G. & Spada, A. G protein mutations in endocrine diseases. Eur J Endocrinol 145, 543-559 (2001). (Pubitemid 33061899)
33. Persani, L. et al. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J Clin Endocrinol Metab 85, 2872-2878 (2000). (Pubitemid 32269166)
34. Otmakhov, N. et al. Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. J Neurophysiol 91, 1955-1962 (2004). (Pubitemid 38500915)
35. Romano, A., Delorenzi, A., Pedreira, M. E., Tomsic, D. & Maldonado, H. Acute administration of a permeant analog of cAMP and a phosphodiesterase inhibitor improve long-term habituation in the crab Chasmagnathus. Behav Brain Res 75, 119-125 (1996). (Pubitemid 26076747)
36. Schneider, H. H. Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem Pharmacol 33, 1690-1693 (1984). (Pubitemid 14147798)
37. Park, S. J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433 (2012).
38. Li, Y. F. et al. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci 31, 172-183 (2011).
39. Dowling-Warriner, C. V. & Trosko, J. E. Induction of gap junctional intercellular communication, connexin43 expression, and subsequent differentiation in human fetal neuronal cells by stimulation of the cyclic AMP pathway. Neuroscience 95, 859-868 (2000).
40. Houslay, M. D. & Adams, D. R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370, 1-18 (2003). (Pubitemid 36259414)
41. Marko, D., Pahlke, G., Merz, K. H. & Eisenbrand, G. Cyclic 39, 59-nucleotide phosphodiesterases: potential targets for anticancer therapy. Chem Res Toxicol 13, 944-948 (2000).
42. Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R.Lane, D. P. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9, 862-873 (2009).
43. Riley, T., Sontag, E., Chen, P. & Levine, A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9, 402-412 (2008). (Pubitemid 351574202)
44. Ricci-Vitiani, L. et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828 (2010).
45. Rodriguez, F. J., Orr, B. A., Ligon, K. L. & Eberhart, C. G. Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 3, 98-106 (2012).
46. Zheng, H. et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455, 1129-1133 (2008).
47. Chow, L. M. et al. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell 19, 305-316 (2011).
48. Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110 (2010).
49. Karin, M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol 6, 415-424 (1994). (Pubitemid 24170014)
50. Copsel, S. et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem 286, 6979-6988 (2011).
51. Louis, D. N. et al. The 2007WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109 (2007). (Pubitemid 47103521)